Courier Capital’s Boston Scientific BSX Stock Holding History

Courier Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.56M	Buy	36,504 +6,246	+21%	+$339K	0.08%	191
2026 Q1	$1.9M	Buy	30,258 +13	+0%	+$1.04K	0.11%	165
2025 Q4	$2.88M	Sell	30,245 -1,128	-4%	-$111K	0.16%	129
2025 Q3	$3.06M	Buy	31,373 +1,005	+3%	+$104K	0.18%	121
2025 Q2	$3.26M	Sell	30,368 -159	-0.5%	-$16.1K	0.2%	113
2025 Q1	$3.08M	Buy	30,527 +8,143	+36%	+$820K	0.2%	115
2024 Q4	$2M	Buy	22,384 +11,661	+109%	+$1.03M	0.14%	134
2024 Q3	$899K	Buy	10,723 +82	+0.8%	+$6.46K	0.06%	200
2024 Q2	$819K	Sell	10,641 -758	-7%	-$55.5K	0.07%	183
2024 Q1	$781K	Buy	11,399 +2,096	+23%	+$135K	0.06%	204
2023 Q4	$538K	Buy	9,303 +58	+0.6%	+$3.1K	0.04%	234
2023 Q3	$488K	Sell	9,245 -13	-0.1%	-$682	0.04%	236
2023 Q2	$501K	Buy	+9,258	New	+$484K	0.04%	242

Other funds holding BSX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Milford Funds Auckland $6.14B AUM

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Banque Transatlantique Paris, France $4.66B AUM 33.26% 1-Year Est. Return

Courier Capital's BSX Position: Q2 2026 in Review

Courier Capital increased its Boston Scientific (BSX) stake by 21% in Q2 2026, buying an estimated $339K and bringing the position to 36,504 shares worth $1.56M. The position accounts for 0.08% of the portfolio, ranked #191.

Courier Capital first reported a position in BSX in Q2 2023 and has held it in 13 quarters since. The position peaked at $3.26M in Q2 2025. 529 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Courier Capital held 36,504 shares of Boston Scientific worth $1.56M as of Q2 2026.
Courier Capital bought 6,246 Boston Scientific shares in Q2 2026, an estimated $339K.
Boston Scientific made up 0.08% of Courier Capital's portfolio in Q2 2026, its #191 holding.
Courier Capital first reported a position in Boston Scientific in Q2 2023 and has held it in 13 quarters since.
Courier Capital's Boston Scientific position peaked at $3.26M in Q2 2025.
529 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Courier Capital's 13F filing for Q2 2026, filed 16 Jul 2026.